Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CSL Ltd

CSLLY
Current price
100.86 USD +0.33 USD (+0.33%)
Last closed 301.51 AUD
ISIN AU000000CSL8
Sector Healthcare
Industry Biotechnology
Exchange AU
Capitalization 144 755 775 177 AUD
Yield for 12 month +10.91 %
1Y
3Y
5Y
10Y
15Y
CSLLY
21.11.2021 - 28.11.2021

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Address: 655 Elizabeth Street, Melbourne, VIC, Australia, 3000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

490.09 AUD

P/E ratio

36.7246

Dividend Yield

1.33 %

Current Year

+33 567 617 180 AUD

Last Year

+29 326 535 947 AUD

Current Quarter

+15 186 433 614 AUD

Last Quarter

+18 393 891 580 AUD

Current Year

+16 340 505 818 AUD

Last Year

+14 173 527 735 AUD

Current Quarter

+6 916 368 268 AUD

Last Quarter

+9 434 471 403 AUD

Key Figures CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 601 289 433 AUD
Operating Margin TTM 19.02 %
PE Ratio 36.7246
Return On Assets TTM 6.56 %
PEG Ratio
Return On Equity TTM 14.58 %
Wall Street Target Price 490.09 AUD
Revenue TTM 14 746 445 535 AUD
Book Value 35.8 AUD
Revenue Per Share TTM
Dividend Share 2.63 AUD
Quarterly Revenue Growth YOY 10.1 %
Dividend Yield 1.33 %
Gross Profit TTM 6 819 234 678 AUD
Earnings per share 8.14 AUD
Diluted Eps TTM 8.14 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 30.7 %
Profit Margin 17.85 %

Dividend Analytics CSLLY

Dividend growth over 5 years

59 %

Continuous growth

2 years

Payout Ratio 5 years average

59 %

Dividend History CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 4
Ex Dividend Date 09.09.2024
Forward Annual Dividend Yield 1.33 %
Last Split Factor 3:1
Payout Ratio 45.18 %
Last Split Date 18.10.2007
Dividend Date

Stock Valuation CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 36.7246
Forward PE 35.5872
Enterprise Value Revenue 7.3322
Price Sales TTM 9.8163
Enterprise Value EBITDA 22.7573
Price Book MRQ 5.6082

Financials CSLLY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSLLY

For 52 weeks

224.75 AUD 310.15 AUD
50 Day MA 304.33 AUD
Shares Short Prior Month
200 Day MA 288.38 AUD
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

0

0LJB

5.15 USD Uniti Group Inc. -0.01 (-0.27%)
Detailed analytics
SO

SO

89.64 USD Southern Company +0.14 (+0.16%)
Detailed analytics
1

1GILD

73.16 EUR Gilead Sciences Inc. +0.5 (+0.62%)
Detailed analytics
F

FI

172.40 USD Fiserv, Inc. -0.45 (-0.26%)
Detailed analytics
1

1NBA

58.08 EUR Anheuser-Busch InBev SA/NV 0 (0%)
Detailed analytics